565 related articles for article (PubMed ID: 15975029)
1. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
van Muiswinkel FL; Kuiperij HB
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
[TBL] [Abstract][Full Text] [Related]
3. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
5. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Di Matteo V; Esposito E
Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802
[TBL] [Abstract][Full Text] [Related]
7. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
8. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanism of neuroprotective drugs against oxidative stress-induced neuronal cell death].
Hara H
Yakugaku Zasshi; 2007 Aug; 127(8):1199-205. PubMed ID: 17666870
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2.
Bahn G; Jo DG
Neuromolecular Med; 2019 Mar; 21(1):1-11. PubMed ID: 30617737
[TBL] [Abstract][Full Text] [Related]
12. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
13. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
14. [Role of Nrf2 in neurodegenerative diseases and recent progress of its activators].
Zhao CY; Wang XL; Peng Y
Yao Xue Xue Bao; 2015 Apr; 50(4):375-84. PubMed ID: 26223117
[TBL] [Abstract][Full Text] [Related]
15. Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity.
Jiang H; Tian X; Guo Y; Duan W; Bu H; Li C
Biol Pharm Bull; 2011; 34(8):1194-7. PubMed ID: 21804205
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria: a therapeutic target in neurodegeneration.
Moreira PI; Zhu X; Wang X; Lee HG; Nunomura A; Petersen RB; Perry G; Smith MA
Biochim Biophys Acta; 2010 Jan; 1802(1):212-20. PubMed ID: 19853657
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases.
Chen XL; Kunsch C
Curr Pharm Des; 2004; 10(8):879-91. PubMed ID: 15032691
[TBL] [Abstract][Full Text] [Related]
18. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.
Johnson JA; Johnson DA; Kraft AD; Calkins MJ; Jakel RJ; Vargas MR; Chen PC
Ann N Y Acad Sci; 2008 Dec; 1147():61-9. PubMed ID: 19076431
[TBL] [Abstract][Full Text] [Related]
19. [Oxidative stress in the neurodegenerative diseases--potential antioxidant activity of catecholamines].
Jodko K; Litwinienko G
Postepy Biochem; 2010; 56(3):248-59. PubMed ID: 21117312
[TBL] [Abstract][Full Text] [Related]
20. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
Kanno T; Tanaka K; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Hirayama N; Ikeda JE
Free Radic Biol Med; 2012 Dec; 53(11):2028-42. PubMed ID: 23000247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
